JP2009543792A5 - - Google Patents

Download PDF

Info

Publication number
JP2009543792A5
JP2009543792A5 JP2009519586A JP2009519586A JP2009543792A5 JP 2009543792 A5 JP2009543792 A5 JP 2009543792A5 JP 2009519586 A JP2009519586 A JP 2009519586A JP 2009519586 A JP2009519586 A JP 2009519586A JP 2009543792 A5 JP2009543792 A5 JP 2009543792A5
Authority
JP
Japan
Prior art keywords
compound according
carbon atoms
prodrug
alkyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009519586A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009543792A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/072632 external-priority patent/WO2008008660A2/en
Publication of JP2009543792A publication Critical patent/JP2009543792A/ja
Publication of JP2009543792A5 publication Critical patent/JP2009543792A5/ja
Withdrawn legal-status Critical Current

Links

JP2009519586A 2006-07-11 2007-07-02 抗緑内障薬としてのシクロペンタン誘導体 Withdrawn JP2009543792A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80694606P 2006-07-11 2006-07-11
US80697206P 2006-07-11 2006-07-11
PCT/US2007/072632 WO2008008660A2 (en) 2006-07-11 2007-07-02 Cyclopentane derivatives as antiglaucoma agents

Publications (2)

Publication Number Publication Date
JP2009543792A JP2009543792A (ja) 2009-12-10
JP2009543792A5 true JP2009543792A5 (enExample) 2010-08-19

Family

ID=38716351

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009519586A Withdrawn JP2009543792A (ja) 2006-07-11 2007-07-02 抗緑内障薬としてのシクロペンタン誘導体

Country Status (7)

Country Link
US (1) US20080015219A1 (enExample)
EP (1) EP2066615A2 (enExample)
JP (1) JP2009543792A (enExample)
AU (1) AU2007272730B2 (enExample)
BR (1) BRPI0714286A2 (enExample)
CA (1) CA2659121A1 (enExample)
WO (1) WO2008008660A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2447065T3 (es) * 2006-07-10 2014-03-11 Allergan, Inc. Derivados de ciclopentano sustituidos como agentes terapeuticos
EP2043993B1 (en) * 2006-07-11 2015-07-01 Allergan, Inc. Cyclopentane derivatives as antiglaucoma agents
DK2170345T3 (da) * 2007-07-03 2013-05-13 Allergan Inc Terapeutiske substituerede cyclopentaner til reduktion af intraokulært tryk
CA2706879A1 (en) * 2007-11-29 2009-06-11 Robert M. Burk Substituted cyclopentanes having prostaglandin activity
US8569349B2 (en) * 2008-05-09 2013-10-29 Allergan, Inc. Therapeutic compounds
WO2009140205A2 (en) * 2008-05-15 2009-11-19 Allergan, Inc. Therapeutic substituted cyclopentanes
US8867820B2 (en) * 2009-10-07 2014-10-21 Microsoft Corporation Systems and methods for removing a background of an image
ES2717481T3 (es) * 2014-02-20 2019-06-21 Allergan Inc Engrosamiento corneal central reducido mediante el uso de profármacos de ésteres hidrófilos de beta-clorociclopentanos
EP3112362B1 (en) * 2014-02-27 2018-09-26 ONO Pharmaceutical Co., Ltd. Compound exhibiting selective ep2 agonist activity
CN106458859B (zh) 2014-06-06 2019-08-30 阿勒根公司 作为治疗性化合物的新型ep4激动剂
EP3327018B1 (en) 2015-07-23 2020-11-25 ONO Pharmaceutical Co., Ltd. 2-(octahydrocyclopenta[b]pyran-2-yl)1,3-thiazole-4-carboxylic acid derivatives and related compounds as ep2 agonists with intraocular pressure lowering activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980700A (en) * 1971-10-07 1976-09-14 G. D. Searle & Co. Prostaglandin intermediates and optically active isomers thereof
DE2346706A1 (de) * 1973-09-17 1975-04-03 Hoechst Ag Neue, nicht natuerlich vorkommende analoga von prostansaeuren und verfahren zu ihrer herstellung
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
JPH07238068A (ja) * 1994-02-24 1995-09-12 Taisho Pharmaceut Co Ltd プロスタグランジンe1類縁体
JP2001527063A (ja) * 1998-12-24 2001-12-25 小野薬品工業株式会社 ω−シクロアルキル−プロスタグランジンE2誘導体
KR20040023707A (ko) * 2001-07-31 2004-03-18 수캄포 아게 안내압항진 및 녹내장의 치료
NZ555945A (en) * 2005-01-14 2011-01-28 Allergan Inc Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions
EP2043993B1 (en) * 2006-07-11 2015-07-01 Allergan, Inc. Cyclopentane derivatives as antiglaucoma agents

Similar Documents

Publication Publication Date Title
JP2009543792A5 (enExample)
JP2009541340A5 (enExample)
JP2009543795A5 (enExample)
WO2008008660B1 (en) Cyclopentane derivatives as antiglaucoma agents
JP2009535426A5 (enExample)
JP2010500976A5 (enExample)
JP2010500416A5 (enExample)
JP2009543794A5 (enExample)
JPWO2012102255A1 (ja) インドール誘導体、またはその薬理学的に許容される塩
JP2008513516A5 (enExample)
JPWO2012102254A1 (ja) インドール誘導体、またはその薬理学的に許容される塩
JP2011500562A5 (enExample)
CN102239164A (zh) 2h-色烯化合物及其衍生物
EP2215084B1 (en) Therapeutic substituted lactams
WO2008008718B1 (en) Cyclopentane derivatives as antiglaucoma agents
JP2009540009A5 (enExample)
JP2009536967A5 (enExample)
JP2011500818A5 (enExample)
WO2011013624A1 (ja) インドール誘導体、またはその薬理学的に許容される塩
WO2008008701B1 (en) Substituted cyclopentane derivatives as therapeutic agents
JP2009535418A5 (enExample)
JP2009538328A5 (enExample)
JP2008520737A5 (enExample)
KR20140098710A (ko) Cetp 억제제로서의 바이아릴 또는 헤테로사이클릭 바이아릴 치환 사이클로헥센 유도체 화합물
JP2010516817A5 (enExample)